Search results for "type 2"

showing 10 items of 1034 documents

Perceiving Need for Lifestyle Counseling

2012

OBJECTIVE To investigate the proportion of individuals at high risk of type 2 diabetes who perceive the need for lifestyle counseling, factors associated with this perception, and whether the perceived need is associated with subsequent attendance in lifestyle intervention. RESEARCH DESIGN AND METHODS Baseline and intervention data were obtained from 10,149 participants in a Finnish National Diabetes Prevention Project. RESULTS In total, 36% of men and 52% of women perceived the need for counseling. Most of the risk factors did not increase the perceived need for counseling. Those agreeing to attend supervised lifestyle intervention were more likely to report a perceived need than those wh…

Advanced and Specialized NursingResearch designGerontologybusiness.industryEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectAttendance030209 endocrinology & metabolismType 2 diabetesLifestyle counselingmedicine.disease3. Good health03 medical and health sciences0302 clinical medicineIntervention (counseling)PerceptionLifestyle changeLifestyle interventionInternal MedicineMedicine030212 general & internal medicinebusinessmedia_commonDiabetes Care
researchProduct

hs-CRP Predicts Improvement in Depression in Patients With Type 1 Diabetes and Major Depression Undergoing Depression Treatment: Results From the Dia…

2016

hs-CRP is elevated in depression (1), but evidence on decreases of hs-CRP during depression treatment or the role of hs-CRP in the prediction of response to depression treatment is still controversial (2,3). To date, no study has examined this association in patients with diabetes. As elevated hs-CRP increases the risk of diabetes complications in diabetes (4), we aimed to explore hs-CRP in patients with diabetes and major depression undergoing depression treatment based on the data of the Diabetes and Depression (DAD) study (5). Participants were randomized to 12 weeks (short-term phase) of diabetes-specific group cognitive behavioral therapy or sertraline treatment and followed up for 15 …

Advanced and Specialized NursingSertralineType 1 diabetesmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentType 2 diabetesmedicine.disease030227 psychiatryCognitive behavioral therapy03 medical and health sciences0302 clinical medicineInterquartile rangeDiabetes mellitusInternal medicineHamdInternal MedicineMedicinebusinessPsychiatry030217 neurology & neurosurgeryDepression (differential diagnoses)medicine.drugDiabetes Care
researchProduct

Éducation thérapeutique structurée par les pairs éducateurs dans le diabète de type 2 au Mali

2016

International audience; Les pays en développement sont confrontés à des ressources financières et humaines limitées, malgré les besoins importants et les défis de santé multiples. Plus de 75% des personnes atteintes de diabète dans le monde vivent dans des pays en développement. En Afrique, le nombre de personnes atteintes de diabète devrait doubler dans les 30 prochaines années.Les défis à relever pour offrir une éducation visant à permettre aux personnes souffrant d'une condition chronique de la gérer eux-mêmes se situent à trois niveaux : les patients, les prestataires de soins, et les systèmes de santé.Au Mali, après le développement de capacités de prise en charge des patients diabétiq…

Afrique[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMalade[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieDiabète non insulinodépendantMaliPays en développementDiabete de type 2Education patient
researchProduct

Aging modifies receptor expression but not muscular contractile response to angiotensin II in rat jejunum

2022

AbstractThe involvement of renin-angiotensin system in the modulation of gut motility and age-related changes in mRNA expression of angiotensin (Ang II) receptors (ATR) are well accepted. We aimed to characterize, in vitro, the contractile responses induced by Ang II, in jejunum from young (3–6 weeks old) and old rats (≥ 1 year old), to evaluate possible functional differences associated to changes in receptor expression. Mechanical responses to Ang II were examined in vitro as changes in isometric tension. ATR expression was assessed by qRT-PCR. Ang II induced a contractile effect, antagonized by losartan, AT1R antagonist, and increased by PD123319, AT2R antagonist, as well by neural block…

AgingJejunumPhysiologyAngiotensin IIAngiotensin II receptorsIntestinal motilityAnimalsGeneral MedicineReceptor Angiotensin Type 2BiochemistryReceptor Angiotensin Type 1LosartanRats
researchProduct

Magnesium in Aging, Health and Diseases

2021

Several changes of magnesium (Mg) metabolism have been reported with aging, including diminished Mg intake, impaired intestinal Mg absorption and renal Mg wasting. Mild Mg deficits are generally asymptomatic and clinical signs are usually non-specific or absent. Asthenia, sleep disorders, hyperemotionality, and cognitive disorders are common in the elderly with mild Mg deficit, and may be often confused with age-related symptoms. Chronic Mg deficits increase the production of free radicals which have been implicated in the development of several chronic age-related disorders. Numerous human diseases have been associated with Mg deficits, including cardiovascular diseases, hypertension and s…

AgingSettore MED/09 - Medicina InternahypertensionOsteoporosisPhysiologylcsh:TX341-641ReviewDiseasemagnesiumdiseaseslongevityDiabetes mellitusFibromyalgiaAnimalsHumansoxidative stressMedicineDementiaosteoporosiWastingDepression (differential diagnoses)AgeddiseaseNutrition and Dieteticsdiabetesbusiness.industryType 2 Diabetes Mellitushealthmedicine.diseaseosteoporosisdiabetemedicine.symptombusinessMagnesium Deficiencylcsh:Nutrition. Foods and food supplydementiaFood ScienceNutrients
researchProduct

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus.

2021

Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diab…

Agingmedicine.medical_specialtyAntioxidantGoto Kakizaki ratsmedia_common.quotation_subjectmedicine.medical_treatmentLongevityGenisteinPhytoestrogensDiseasemedicine.disease_causeAntioxidants03 medical and health scienceschemistry.chemical_compoundfluids and secretions0302 clinical medicineStress PhysiologicalInternal medicineMedicineAnimals030304 developmental biologymedia_common2. Zero hunger0303 health sciencesbusiness.industryLongevityfood and beveragesType 2 Diabetes MellitusIsoflavonesAnimal FeedIsoflavones3. Good healthRatsOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Soya030220 oncology & carcinogenesisAntioxidant enzymesPhytoestrogensSoybeansbusinessOxidative stressDevelopmental BiologyMechanisms of ageing and development
researchProduct

What are the roles of calorie restriction and diet quality in promoting healthy longevity?

2014

Epidemiological and experimental data indicate that diet plays a central role in the pathogenesis of many age-associated chronic diseases, and in the biology of aging itself. Data from several animal studies suggest that the degree and time of calorie restriction (CR) onset, the timing of food intake as well as diet composition, play major roles in promoting health and longevity, breaking the old dogma that only calorie intake is important in extending healthy lifespan. Data from human studies indicate that long-term CR with adequate intake of nutrients results in several metabolic adaptations that reduce the risk of developing type 2 diabetes, hypertension, cardiovascular disease and cance…

Agingmedicine.medical_specialtyDisease preventionTime Factorsmedia_common.quotation_subjectLongevityCalorie restrictionNutritional StatusPhysiologyType 2 diabetesDiseaseBiologyVegetarian dietBiochemistryCalorie restriction Diet quality Health Lifespan Vegetarian diet Disease preventionLife ExpectancyNutrientNeoplasmsInternal medicinemedicineAnimalsHumansLife StyleMolecular BiologyCalorie restrictionCaloric Restrictionmedia_common2. Zero hungerLifespanAge FactorsLongevityCalorie restriction; Diet quality; Disease prevention; Health; Lifespan; Vegetarian diet; Age Factors; Aging; Animals; Cardiovascular Diseases; Energy Metabolism; Humans; Longevity; Neoplasms; Nutritional Status; Time Factors; Caloric Restriction; Diet; Life Expectancy; Life Style; Risk Reduction BehaviorVegan Dietmedicine.diseaseDiet3. Good healthEndocrinologyNeurologyHealthCardiovascular DiseasesDietary Reference IntakeAnimal studiesEnergy MetabolismRisk Reduction BehaviorDiet qualityBiotechnology
researchProduct

Magnesium and type 2 diabetes.

2015

Type 2 diabetes is frequently associated with both extracellular and intracellular magnesium (Mg) deficits. A chronic latent Mg deficit or an overt clinical hypomagnesemia is common in patients with type 2 diabetes, especially in those with poorly controlled glycemic profiles. Insulin and glucose are important regulators of Mg metabolism. Intracellular Mg plays a key role in regulating insulin action, insulin-mediated-glucose-uptake and vascular tone. Reduced intracellular Mg concentrations result in a defective tyrosine-kinase activity, postreceptorial impairment in insulin action and worsening of insulin resistance in diabetic patients. A low Mg intake and an increased Mg urinary loss app…

Agingmedicine.medical_specialtySettore MED/09 - Medicina InternaDiabetes riskEndocrinology Diabetes and Metabolismmedicine.medical_treatmentType 2 diabetesHypomagnesemiaInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineMagnesiumEndotheliumAging; Endothelium; Hypertension; Inflammation; Insulin resistance; Magnesium; Metabolic syndrome; Type 2 diabetesGlycemicInflammationbusiness.industryInsulinInsulin resistanceType 2 diabetesMinireviewsmedicine.diseaseMetabolic syndromeEndocrinologyHypertensionMetabolic syndromebusinessWorld journal of diabetes
researchProduct

Postprandial Hyperglycemia Is Associated With White Matter Hyperintensity and Brain Atrophy in Older Patients With Type 2 Diabetes Mellitus

2018

Type 2 diabetes mellitus is associated with neurodegeneration and cerebrovascular disease. However, the precise mechanism underlying the effects of glucose management on brain abnormalities is not fully understood. The differential impacts of glucose alteration on brain changes in patients with and without cognitive impairment are also unclear. This cross-sectional study included 57 older type 2 diabetes patients with a diagnosis of Alzheimer's disease (AD) or normal cognition (NC). We examined the effects of hypoglycemia, postprandial hyperglycemia and glucose fluctuations on regional white matter hyperintensity (WMH) and brain atrophy among these patients. In a multiple regression analysi…

Agingmedicine.medical_specialtyendocrine system diseasesCognitive Neuroscience030209 endocrinology & metabolismDiseaseType 2 diabetesHypoglycemialcsh:RC321-57103 medical and health sciences0302 clinical medicineAtrophyDiabetes mellitusInternal medicineMedicineCognitive declinepostprandial hyperglycemialcsh:Neurosciences. Biological psychiatry. Neuropsychiatrybusiness.industrywhite matter hyperintensityType 2 Diabetes Mellitusmedicine.diseasePostprandialdiabetes mellitusCardiologybusinessAlzheimer’s diseasebrain atrophy030217 neurology & neurosurgeryFrontiers in Aging Neuroscience
researchProduct

Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy.

2014

This study aimed at providing an insight on the possible role of cannabi-noid (CB) type 2 receptors (CB2R) and cGMP pathway in the antiepileptic activity ofWIN 55,212-2, (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-Yl]-1-naphthalenylmethanone, a non-selective CB agonist, in the maximal dentate activation (MDA) model of partial epilepsy in adult male rats. We evaluated the activity of a CB2 antagonist/inverse agonist AM630, [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone or 6-iodopravadoline, alone or in co-administration with WIN 55,212-2. Also, in the MDA model it was investigated the co-treatment of WIN55,212…

AgonistMaleIndolessGCmedicine.drug_classmedicine.medical_treatmentMorpholinesPharmacologyNaphthalenesSettore BIO/09 - FisiologiaHippocampusNitric oxideReceptor Cannabinoid CB2chemistry.chemical_compoundHippocampumedicineCannabinoid receptor type 2Inverse agonistAnimalsRats WistarReceptorCannabinoidCannabinoid Receptor AntagonistsCyclic GMPCannabinoid Receptor AgonistsElectrophysiology.ChemistryAntagonistElectric StimulationBenzoxazinesDisease Models AnimalNeurologyGuanylate CyclaseAnticonvulsantsNeurology (clinical)CannabinoidEpilepsies PartialSoluble guanylyl cyclaseTemporal Lobe Epilepsy AM630Epilepsy research
researchProduct